CXCR3 and inflammatory bowel disease: Reduced levels of IFN-y in DSS-challenged KO mice suggests a reduced CXCR3-mediated neutrophil insult in the inflamed colon, potentiating the blockade of CXCR3 in reducing intestinal injury in patients with IBD.